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 INTRODUCTION – THE TWO 
HOMEOSTATIC SYSTEMS
While the system that controls body water solute 
concentration (osmolality) – let us call it ADH/thirst 
system- rapidly responds (in a matter seconds to 
minutes) to small variations by setting in motion 
potent correcting mechanisms (changes in the drive 
for water ingestion and in the urine dilution or con-
centration) that finally return that concentrations to 
normal values within narrow fluctuation limits, the 
system that controls the volume of the extracellular 
fluid does so in a much slower way (in hours or 
days), is less precise and does not always return 
the volume to the value preceding the external chal-
lenge, settling for a limited stability that consists in 
only trying to match further gains with losses (I shall 
return to this point).
A small change in water balance (due to increased 
intake or exclusive water loss) translates into a 
change in osmolality (dilution or concentration), 
which, even if small, through the ADH/thirst system 
changes the behavioural and renal effector responses, 
eliminates or acquires water, and brings the body 
solute concentration back to the previous normal 
values. In this process it is not necessary to take 
into account the small variation in extracellular vol-
ume because its regulating system is practically not 
called into action.
Let us consider now, as an example, a sudden 
increase in the intake of hypertonic sodium chloride 
(salted chips…): there is a rapid rise in osmolality 
which leads, through the ADH/thirst system to a 
positive water balance and, soon, what persists is 
an isotonic rise in extracellular fluid volume, setting 
then in motion the volume control system. Even with 
excess hypotonic sodium chloride ingestion there 
will be a noticeable negative water balance, leaving 
as before an increase in isotonic extracellular fluid 
volume (albeit of a smaller magnitude) triggering 
the volume control system adaptation2.
As a mental framework, it is convenient to think 
in terms of two systems: consider water metabolism 
resulting in solute concentration and under the con-
centration regulation system supervision and, on the 
other side, salt metabolism resulting in extracellular 
fluid volume and under the volume regulation system 
supervision.
This is obviously an oversimplification and the 
two control systems are not completely independent. 
It is important to consider the dual control (or, to 
be more precise, multifactorial control) of ADH secre-
tion: under situations of marked hypovolemia there 
is an increase in ADH secretion and in thirst, resulting 
in some sacrifice of tonicity for the preservation of 
fluid volume. In situations of diminished effective 
arterial volume there is also a “non-osmotic” stimulus 
for ADH secretion- hyponatremia of congestive heart 
failure for instance. Again there are other known 
non-osmotic stimuli for ADH secretion, but keeping 
the list in mind (or readily available in electronic 
sources), the merits of the conceptual and didactic 
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approach of always considering the two homeostatic 
systems cannot be overstated3.
 VOLUME REGULATION
Due to the fact that sodium is by far the main 
extracellular cation and exists in a fixed concentra-
tion, its total body quantity determines the volume 
of the extracellular fluid. Under normal conditions 
the extracellular volume also has a strict correlation 
with the intravascular volume.
The system controlling volume is conceptually 
rather more complicated than the one controlling 
concentration. There are low-pressure sensors and 
high-pressure sensors, respectively in the venous 
and arterial sides of the circulation. The signals they 
transmit to the central integrator can be antagonistic 
(for instance augmented pressure in low-pressure 
baroreceptors and diminished pressure in high-pres-
sure baroreceptors, in cardiac failure).
The general picture is even more complicated in 
reality, given the fact that the filling volume of ves-
sels does not translate linearly and univocally into 
pressure: pressure is also determined by pump out-
put, peripheral resistance and compliance of vessels, 
which can, by changing distensibility (mainly in 
veins), accommodate varying volumes without great 
pressure changes. Additionally, there are different 
behaviours in local vascular territories, with vaso-
constriction in certain areas and vasodilation in 
others.
As a result, there is not, as yet, a unifying and 
comprehensive algorithm that can explain the regula-
tion of sodium balance in normal physiology and in 
disease situations.
The pattern that seems to emerge is one of a 
slow and relatively imprecise control of sodium bal-
ance when the situation is dealing with small to 
moderate variations in intake or losses, mediated 
mainly by low-pressure baroreceptors as long as 
high-pressure sensing changes are not large. In these 
settings, a stable situation can be reached with the 
net balance becoming 0, even though the previous 
gain (or loss) persists if under 2 litres of extracellular 
fluid (with inter-individual variability).
How can one explain the behaviour of the control 
system in situations in which, retaining functionality, 
it “allows” the accumulation of large excess extracel-
lular fluid (generalized oedema)? The common expla-
nation is that what prevails among conflicting stimuli 
is the effective arterial blood volume, due to the fact 
that an adequate tissue perfusion better guarantees 
survival.
Effective arterial blood volume (EABV) is not mea-
sured directly by any sensor: even arterial barorecep-
tors, responding to vessel wall distension, closely 
related to intraluminal pressure, which in turn 
depends on blood flow, peripheral resistance and 
distensibility of the artery itself, do not measure 
EABV. EABV is more of a theoretical construct invoked 
to give coherence to the whole regulation system: 
when tissue perfusion is under menace (due to a 
low EABV), sodium retaining mechanisms are put to 
work even though the extracellular volume is already 
clearly expanded (oedema presence).
Situations like hepatic cirrhosis, nephrotic syn-
drome, congestive heart failure are the typical exam-
ples of the conflicts that may arise out of the messages 
sent by the various receptors of the volume control 
system and of how the central integration ends up 
being done, prevailing the “interpretation” of dimin-
ished EABV over an expanded extracellular volume.
There are known semiological difficulties in the 
evaluation of euvolaemia even with the aid of sophis-
ticated auxiliary diagnostic means (isotopic dilution 
measures of total body water, vena cava size and 
distensibility). There are no normal limits to whatever 
is evaluated as a measure of volaemia. Euvolaemia 
is a relative concept: it is the best value for that 
person in those circumstances. That explains the 
frequent need in clinical practice to the use of the 
“tentative fluid challenge”, a trial and error manoeu-
vre to exclude eventual undetected functional 
hypovolemia.
In all these situations the volume control system 
is fully operational and there is a trade-off optimiza-
tion of circulatory and volume adjustments to respond 
to the pathological dysfunction (hypoalbuminaemia, 
portal hypertension, vasodilation in hepatic cirrhosis, 
for instance). More rarely it is the control system 
itself that is responsible for the pathological changes 
(autonomic dysfunction).
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 EXTRACELULAR VOLUME AND 
EFFECTIVE ARTERIAL BLOOD VOLUME
 a) Compartments
The Na-K ATP dependent pumps located on the 
cell membranes transport Na out of cells and, inverse-
ly, K inside, making Na the main solute of the extra-
cellular fluid and K the one of the intracellular com-
partment. Water diffuses freely between those 
compartments. Water represents 50% (in women) to 
60% (in men) of total body weight.
As we have seen, total body Na content determines 
the volume of extracellular fluid (ECF), 1/3 of total 
water under normal conditions.
The second barrier in body water is the capillary 
wall, dividing extracellular water in two compart-
ments: interstitium and intravascular. The transport 
determinants at this interface are well described by 
Starling forces (hydrostatic and colloid-osmotic forces 
along the capillary wall). Interstitial volume is 3/4 of 
the extracellular volume while the intravascular is 
1/4.
The volume of the extracellular fluid is kept within 
limits by homeostatic mechanisms which oppose 
disturbances resulting from variable intakes or 
losses.
In general, fluctuations in ECF volume run in paral-
lel with intravascular volume except when there are 
changes in Starling forces (decreased oncotic pres-
sure, for instance), or when, as referred above, keep-
ing EABV overrides avoiding excess ECF volume 
(which seems like a regulation failure).
 b) Regulation
Volume regulation can be approached considering 
an afferent limb with sensors collecting pressure 
data, central integration of that information by the 
nervous system, with a response consisting on an 
increase or decrease in sodium and water excretion 
mediated by an efferent limb intervening on kidneys 
and vasomotor tone.
Here is a short description of the two limbs and 
the resulting integration4.
Afferent limb
There are pressure/stretch sensors located in stra-
tegic places of the vasculature: low-pressure cardio-
vascular sensors (in the auricles, ventricles and pul-
monary vessels), arterial high-pressure baroreceptors 
(carotid, aortic arch and renal vessels) and sensors 
in the central nervous system and in the liver 
vessels.
The existence of sensors in several territories 
allows for a differentiated monitoring: a sodium 
overload expands the ECF, situation that will be 
“recognized” through auricle distension, increasing 
the production of atrial natriuretic peptide (ANP) and 
leading to natriuresis by the latter action on the 
kidneys culminating in a new steady balance; a 
descent of systemic arterial pressure will be sensed 
by carotid baroreceptors leading to sympathetic acti-
vation (vasoconstriction and tendency for sodium 
retention), but the response may depend on whether 
the hypotension is caused by hypovolaemia (ex. 
haemorrhage) or cardiac failure, in which case the 
heightened ventricular pressure can dampen sodium 
retention through ANP or brain natriuretic peptide 
(BNP) secretion.
The feedback loops may be predominantly neural 
and local but often also involving e humoral com-
ponents that may have systemic effects: juxtaglo-
merular apparatus sensing/modulating the secretion 
of renin; and changes in tubular flow and composition 
determining haemodynamic changes in glomerular 
circulation.
Efferent limb
Various mechanisms involving the renal handling 
of sodium (and also arteriolar tone) can be listed as 
effector responses in homeostatic constant volume 
preservation.
Sympathetic: sympathetic nerve endings reach affer-
ent and efferent glomerular arteriole cells, as well as 
juxtaglomerular apparatus and renal tubule cells. 
Sympathetic stimulation has a net sodium retention 
effect as well as selective vasoconstriction. These 
actions are direct and indirect. Renal nerves change 
the tone of afferent and efferent arterioles increasing 
filtration fraction (FF) which predisposes to sodium 
retention. They also directly stimulate proximal tubule 
cell sodium reabsorption and also the secretion of 
renin by the juxtaglomerular apparatus. This activation 
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of the renin/angiotensin axis amplifies the direct effects 
on the kidney sodium handling.
Renin/Angiotensin/Aldosterone System: the libera-
tion of renin, determined by sympathetic stimulation 
or through the juxtaglomerular apparatus leads to 
activation of angiotensin I, and by action of the 
angiotensin-converting enzyme to angiotensin II (Ang 
II). Ang II has a systemic vasoconstrictor effect but 
predominantly causes vasoconstriction of the efferent 
arteriole, acts directly on proximal tubule cells and, 
in positive feed-back loop increases sympathetic 
neuro-transmission. Additionally, it stimulates the 
production of aldosterone. All these actions converge 
in to increase sodium reabsorption.
Prostaglandins: PGI2 mediates the Renin produc-
tion by the baroreceptor; PGE2, whose production 
is stimulated by Ang II, AVP and catecholamines, 
has a renal vasodilatory effect and inhibits water 
and salt reabsorption, dampening the renal effect of 
the very hormones that lead to its production, so, 
basically maintaining renal function (effect that is 
jeopardized when inhibited by the administration of 
non-steroidal anti-inflammatories).
AVP: As we shall see, the production of AVP, 
although strictly linked to the regulation of osmolal-
ity, is also stimulated by low circulatory volume. It 
has a vasoconstrictor effect (in high concentration 
– V1 receptors), and leads to water retention and 
increases sodium reabsorption and potassium excre-
tion (partly in synergistic action with aldosterone)
Natriuretic peptides: ANP (auricles) and BNP (ven-
tricles) are peptides that stimulate diuresis, natriure-
sis and vascular muscle relaxation, through actions 
on the glomerulus, tubule and decreasing renin and 
aldosterone secretion; a similar peptide, CNP, pro-
duced by endothelial cells can have a role in local 
regulation.
Direct effect of blood pressure (Pressure Natriure-
sis): A rise in arterial pressure leads to a marked 
natriuretic response, even without the intervention of 
the usual neuro-humoral mediators (it seems to be 
mediated locally in the kidney by a rise in nitric oxide).
Integration
We do not have, as yet, an integrated vision of 
the whole operation of the several mechanisms to 
be able to build a satisfactory model3. How does 
occur the integration of the information which would 
lead by itself to opposing responses? How is the 
information from different territories integrated? Is 
there recruitment of effectors under greater distur-
bances? Is there a hierarchy of signal meanings and 
of responses?
It seems there is a complex integration with a 
“logic” of recruitment: when the first line adaptive 
response reveals itself to be insufficient then others 
are called into action in succession, eventually more 
“primitive”, coarser and less fine-tuned but eventu-
ally more powerful. Some proof for this comes from 
the observation of the escape phenomena (escape 
from diuretic action, escape from aldosterone) and 
also the pressure-natriuresis data- when one experi-
mentally fixes renin-aldosterone system in either low 
or high levels, it is then through the rise in blood 
pressure (renal perfusion pressure) that natriuresis 
follows the rise in salt intake and balance is reached. 
Facing persistent alterations away from equilibrium 
the subtler mechanisms are overridden by a stronger, 
simpler one (perfusion pressure itself) that creates 
a new 0 balance situation, although with different 
operational parameters – it takes a higher blood 
pressure to excrete the exceeding salt.
The complete hierarchy of recruitment is not 
known. We only recognize general patterns.
Figure 1
Pressure natriuresis
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Apparently small, day-to-day changes in sodium 
intake or loss are dealt with by the actions on col-
lecting tubules of varying levels of ANP or aldoste-
rone, inducing the renal handling of sodium in the 
opposite direction of the detected change, correcting 
the disturbance and bringing body composition back 
to basal values.
When the disturbance is more severe or sudden, 
additional mechanisms are recruited with increasing 
levels of sympathetic activation and when the prob-
lem arises in the effector neuro-hormonal limb itself, 
there can be a homeostatic response, determined 
solely and directly by the arterial perfusion pressure 
on the kidneys (autoregulation).
 c) Clinical setting
The clinical situations relating to extracellular vol-
ume are naturally dominated by volume contraction 
or expansion. It must be stressed out again that the 
clinical evaluation of the patient´s volemia is neither 
easy nor rigorous in situations of small deviations 
from normal/ideal values.
In volume depletion it is usual to start by trying 
to ascertain if the cause is renal (renal structures like 
tubules or effector deficiency) or if, by contrast, the 
losses are extra-renal (and the kidney is either actu-
ally reacting in an homeostatically adequate way or, 
by contrast its capacity has been overwhelmed).
In situations of volume overload it is also custom-
ary to start by trying to find out if sodium retention 
is primarily renal (renal “disease”) or if it is a sec-
ondary response to a decrease in effective arterial 
blood volume (cardiac failure, hepatic failure or 
nephrotic syndrome, mainly).
 OSMOLALITY-NATREMIA
 a) Compartments; typical balance
Osmolality depends on the number of free mol-
ecules in a certain amount of solvent. It is usually 
calculated as twice sodium concentration (it is 
assumed anions equal cations, so twice the concen-
tration of the major cation is used) plus the 
concentration of glucose molecules (glucose in mg 
divided by its molecular weight-18) plus the molecular 
concentration of urea (concentration of urea divided 
by 6). This value would be identical to the reading 
obtained directly in an osmometer. Bigger molecules 
represent a small number of particles due to their 
large molecular weight and have a usually ignored 
impact.
We have seen that water diffuses freely through 
cell membranes, moving to the side with the higher 
tonicity and until, by the ensuing dilution, concentra-
tions become equal and net water movement stops.
Urea and glucose have different biological behav-
iours, however: urea passes almost freely the mem-
branes of most cells, its concentration is the same 
intra- and extracellularly and so it exerts no osmotic 
effect. As to glucose, it does not cross cell membranes 
so easily and so it does exert an osmotic effect, 
driving water out of cells when it rises markedly in 
extracellular fluid, inducing some decrease in cell 
volume and dilution of the components of the extra-
cellular fluid, namely sodium, with resulting 
hyponatremia.
In urine the main osmols are the electrolytes 
(sodium, potassium and chloride), ammonia and urea. 
Urea is one of the main determinants of urine osmo-
lality and, contrary to what happens in the rest of 
the organism, in the kidney it exerts a marked 
osmotic effect due to varying urea and water perme-
abilities along the nephron. The amount of daily 
osmols eliminated by the kidney to keep 0 net bal-
ance depends on the diet, basically the amount of 
salts and protein ingested.
Changes in extracellular fluid tonicity determine 
variations in cell size by the influx or outflux of water 
down the osmotic gradient. Central nervous system 
cells being contained inside a rigid skull may suffer 
from acute changes in size and there are protective 
mechanisms to generate or get rid of intracellular 
osmols, although slow to develop.
Under typical conditions water drinking will range 
from 400 ml (obligatory minimum) to 1400 ml; 850 
ml from water contained in foods will be added to 
intake; 350 ml of water from the oxidation of food 
in metabolic processes is also added; the body then 
“receives” a total of 1600 to 2600 ml of water a day. 
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In the same time period the water output is 500ml 
(minimum) to 1500 ml in urine; 500 ml in sweating/
perspiration; 400 ml through respiration in expired 
saturated air; and about 200 ml in faeces. The organ-
ism is in balance. It is obvious that these are usual 
values. Skin water loss can increase markedly with 
heat or in fever; water in faeces can increase in 
diarrhoea. The minimum volume of daily diuresis 
(under which oliguria is present) is determined by 
the maximal concentrating capacity reachable by the 
kidneys (1400 mOsm/Kg) to eliminate 700 to 800 
mOsm generated by a normal diet. Usually most 
people eliminate these osmols in a much more 
diluted urine.
 b) Regulation
Tonicity of the extracellular fluid is actively kept 
within very narrow limits, around 288 mOsm/L, 
through the variation in daily water output in urine 
(from 500 ml to 12 000 ml) and also through induc-
tion of appropriate water drinking behaviour (thirst 
or lack of it). It is remarkable thirst can be such a 
strong motivation, becoming, in extreme situations, 
the sole determinant of behaviour and completely 
filling the field of consciousness!
Osmoreceptors in the hypothalamus control thirst 
and the secretion of ADH, the effector limb, which, 
acting on the kidney is responsible for varying urinary 
dilution.
As can be seen in Figure 2, regulation is very 
tight: below 280 mOsm/L of plasma osmolality ADH 
is not secreted, there is no thirst and urine is dilute 
(minimum osmolality 40 to 100 mOsm/L); a little 
above 280 ADH starts being secreted in rising 
amounts and urine osmolality also rises gradually; 
when urine is isotonic (300 mOsm/L) one can be 
sure ADH is being secreted; at 290 mOsm/L thirst 
sets in and urine becomes increasingly concentrated 
(maximum value 1200 mOsm/L.
Due to the fact that, mainly in the ascending limb 
of Henle’s loop, sodium is reabsorbed from the tubu-
lar fluid not accompanied by water, hypotonic (intra-
tubular) and hypertonic (interstitium) fluids are gen-
erated (the effect is amplified by counter current 
multiplication mechanisms). The intratubular hypo-
tonic fluid can be eliminated as such if the remaining 
tubule is kept impermeable to water, or it can be 
concentrated by water outflowing towards the hyper-
tonic interstitium if the tubule is rendered permeable 
to water through the action of ADH.
It is clear that reaching extremes of maximal con-
centration or dilution depends on additional factors, 
namely intratubular flow (which varies with ECF vol-
ume), the solute load to excrete (protein and solute 
poor diets hamper attaining maximal values). And 
it obviously depends on the structural and functional 
integrity of the control system and kidney.
The ADH secretion is not solely dependent on 
tonicity, it also depends on efective arterial blood 
volume and rises when the latter is diminished, lead-
ing to water conservation which tends to dampen 
volume contraction but at the “price” of a lowered 
tonicity (hyponatremia). As we have seen contraction 
of EABV can occur with a truly diminished ECF volume 
(salt losses) or with an expanded ECF (hyponatremia 
of heart failure). One must consider other indepen-
dent stimuli to ADH secretion: pain, anxiety, several 
drugs and Ang II itself.
To quantify the degree of urine dilution or con-
centration we can use some useful concepts, like 
free-water clearance (or reabsorption) and electrolyte-
free water reabsorption. Basically, produced urine is 
considered as being divisible in two parts: one vol-
ume, containing all the solutes (osmols) in isotonic 
concentration with the plasma, and another volume 
of solute free water. If the urine is diluted then the 
Figure 2
Response to changes in serum osmolality
(Adapted from: Comprehensive Clinical Nephrology, 4th Edition Floege J, Johnson RJ, 
Feehally J. St. Louis: Saunders/Elsevier, 20101).
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volume of free water is positive and can be thought 
off as the amount of water that is being removed 
from the ECF. On the contrary, if the urine is con-
centrated regarding the plasma, the volume of free 
water is negative (reabsorption of free water) and 
the volume of free water equals the amount of water 
that is being added to the ECF.
As we have seen, urine osmolality depends not 
only on electrolytes but also on urea and ammonia. 
As the prime determinants of plasma osmolality are 
its ions, one may wish to focus on the effects of 
urine water on the concentration of the ions. We 
then measure electrolyte-free water reabsorption and 
consider real urine divided into two parts: one that 
has all the electrolytes in a concentration equal to 
plasma and another volume of electrolyte-free water. 
Again if the value is positive, it means this volume 
is being added to the plasma, this time diluting 
sodium (urinary urea and ammonia that are present 
independently of the electrolyte content of the urine 
are left out of the calculation).
 c) Clinical setting
We propose a structured approach to the analysis 
of disturbances of ionic equilibrium, going through 
several steps in succession:
Try to establish if the disturbance to homeostasis 
is recent and still challenging the adaptive mecha-
nisms (induction phase) or if, on the contrary, a 
steady state (or balance) has been reached even at 
values somewhat far from normal.
Evaluate carefully ECF volume and try to define 
the situation as volume depletion, volume overload 
or grossly normal. If there is ECF volume expansion, 
try to characterize the situation in terms of the EABV, 
bearing in mind the situations where there is a 
decrease in this latter parameter (cardiac failure, 
nephrotic syndrome and liver cirrhosis)
Only then consider natremia, as its meaning is 
completely different in the different clinical settings 
already outlined in the two previous steps (the same 
value of hyponatremia would have completely dif-
ferent clinical meaning in the setting of volume con-
traction yet in induction phase or in normal volume, 
in balance).
This approach is the basis for a rational, physiol-
ogy-based search for the correct choice of tests and 
final diagnosis.
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